StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca rare Disease (Alexion) — Emerging Markets product sales ($M) ($M)

Form 6-K / 20-F Therapy Area Product Sales Table

QuarterlyAnnual
Latest, Q2 2026
305
Period ended Jun 30, 2026
Change on a year earlier
+9.7%
278 in Q2 2025
History
20 quarters
Since Q3 2021
Sources
20
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRare Disease (Alexion) — Emerging Markets product sales ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026305+9.7%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 2026347+69.3%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 2025248+12.2%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 2025307+76.4%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 2025278+36.9%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 2025205-18.3%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 2024221+62.5%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 2024174+6.7%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 2024203+35.3%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 2024251+45.1%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 2023136+17.2%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 2023163+48.2%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 2023150+64.8%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 2023173+50.4%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 2022116-11.5%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 2022110+69.2%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up rare disease (alexion) — emerging markets product sales ($m)

Cite this data

StockData. (2026). AstraZeneca Rare Disease (Alexion) — Emerging Markets product sales ($M) ($M), quarterly Q3 2021–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/ta_rare_em

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.